Lifestyle interventions are cheaper but produce substantially less weight loss on average
This led to the US FDA approval of Ozempic to reduce cardiovascular risk in this specific patient population in 2020 In the HARMONY Outcomes trial, patients with type 2 diabetes and cardiovascular disease who took the GLP-1 medication saw a 22% reduction in major adverse cardiovascular events compared to placebo
Type 2 diabetes itself is associated with modestly increased colorectal cancer risk, independent of medication use
The sun is shining, the boardwalks are crowded, Wawas hoagiefest is looming, and the summer is here
And the drug "meets our expectations for safety and tolerability," matching injectable GLP-1 drugs' safety profile, Lilly CEO David Ricks said in a statement
doi:10.1007/s00125-022-05787-2 7